uncl posts
FeedPosted Aug 30th 2007 10:57AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Analyst reports, Analyst initiations, Stocks to Buy, Stocks to Sell
MOST NOTEWORTHY: Popular (BPOP), MRU Holdings (UNCL), CDC Corp (CHINA) and Oscient Pharmaceuticals (OSCI) were today's noteworthy initiations:
- Kaufman initiated Popular (NASDAQ: BPOP) with a Hold rating and $13 target, citing the company's direct exposure to nearly $2B of Alt A residential mortgage loans originated by its U.S. operations and approximately $250M of exposure to another $4B of collateralized, securitized mortgage pools.
- MRU Holdings (NADSAQ: UNCL) was initiated with a Buy rating and $8.50 target at Roth Capital. Roth Capital believes MRU Holdings is on the threshold of potentially explosive growth in the fast growing segment of the education lending market, that of private loans.
- JMP Securities said CDC Corp. (NASDAQ: CHINA) , with its resources and connections in China, has excellent deal flow and has been a disciplined, value oriented buyer, and started shares with a Market Outperform and $10.50 target.
- Piper believes Oscient Pharmaceuticals (NASDAQ: OSCI) experienced management team and PCP sales force are competitive advantages and will lead to attractive partners. Piper initiated Oscient Pharmaceuticals with an Outperform rating and $5 target...
OTHER INITIATIONS:
- Raymond James started SAIC (NYSE: SAI) with a Market Perform rating.
- Dice Holdings (NYSE: DHX) was initiated with an Overweight rating and $15 target at Morgan Stanley.
- RBC Capital initiated VMware (NYSE: VMW) with a Sector Perform rating and $75 target.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).Posted Aug 10th 2007 11:30AM by Kevin Shult (RSS feed)
Filed under: Analyst reports, CVS Corp (CVS), Analyst initiations, Stocks to Buy, Stocks to Sell
MOST NOTEWORTHY: MRU Holdings (UNCL), CVS/Caremark (CVS), Medco Health (MHS) and Blackboard (BBBB) were today's noteworthy initiations:
- Kaufman Bros. expects MRU Holdings (NADAQ: UNCL) to post a profit in Q4 for the first time due to its first student loan securitization and started shares with a Buy rating and $9 target.
- Thomas Weisel believes shares of CVS/Caremark (NYSE: CVS) represent a compelling risk/reward at these levels, initiating shares with an Overweight rating and $51 target, given the positive trends in the market and the likelihood of successful merger integration.
- Thomas Weisel believes Medco Health (NYSE: MHS) is well positioned to capitalize on continued generic conversions, starting shares with an Overweight rating and $100 target.
- Banc of America would be buyers of Blackboard (NASDAQ: BBBB) current levels, initiating shares with a Buy rating and $50 target, given the company's defensible business model and market leadership position.
OTHER INITIATIONS:
- Leerink Swann initiated Phase Forward (NASDAQ: PFWD) with a Market Perform rating and $19-$20 valuation range.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).
Will Rich Ross really have a positive impact on Disney's movie operations?
Consumers sick of recession, may spend extra on holidays
Corrections, seasonality and Santa Claus
